# Cerebral Protection in Transcatheter Aortic Valve Replacement

Study · id `cardio:ct-nct02214277` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02214277](<https://clinicaltrials.gov/study/NCT02214277>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT02214277

Browse, organ or system: Heart  
Browse, condition area: Valve and congenital heart disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 363 participants.

## Technical summary

Registry record NCT02214277. Randomized; double masking; primary purpose prevention. Start 2014-09 (registry gives no type); primary completion 2016-03 (actual). Results posted on 2018-05-11.

## Key facts

- Design: Interventional study; randomized; double masking; primary purpose prevention
- Phase: Not applicable
- Enrolled: 363 participants (enrolled count; ClinicalTrials.gov record NCT02214277, source copy `cardio:ctgov-nct02214277-2018-05-11`, retrieved 2026-10-26)
- Start date: 2014-09 (registry gives no type) (ClinicalTrials.gov record NCT02214277, source copy `cardio:ctgov-nct02214277-2018-05-11`, retrieved 2026-10-26)
- Primary completion: 2016-03 (actual) (ClinicalTrials.gov record NCT02214277, source copy `cardio:ctgov-nct02214277-2018-05-11`, retrieved 2026-10-26)
- Completion: 2016-06 (actual) (ClinicalTrials.gov record NCT02214277, source copy `cardio:ctgov-nct02214277-2018-05-11`, retrieved 2026-10-26)
- Results first posted: 2018-05-11 (ClinicalTrials.gov record NCT02214277, source copy `cardio:ctgov-nct02214277-2018-05-11`, retrieved 2026-10-26)
- Countries: United States; Germany (ClinicalTrials.gov record NCT02214277, source copy `cardio:ctgov-nct02214277-2018-05-11`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02214277-2018-05-11`, retrieved 2026-10-26)

## The registry's words

- Brief title: Cerebral Protection in Transcatheter Aortic Valve Replacement
- Condition: Severe Symptomatic Calcified Native Aortic Valve Stenosis
- Intervention (Device): Cerebral Protection System-The SENTINEL System with TAVR
- Intervention (Device): TAVR
- Lead sponsor: Claret Medical
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Aortic stenosis (`cardio:aortic-stenosis`)
- Registry condition terms include this condition: Heart valve disease (`cardio:heart-valve-disease`)

### Other papers using this trial's data

- Registry lists this paper as a reference of type result; PubMed dates it on or after the trial start and types it as a trial report, neither its types nor its title mark it as a protocol, a review or a comment, the paper names no other trial in place of this one, and PubMed shows no retraction or expression of concern; it is not marked as the trial's main report: Protection Against Cerebral Embolism During Transcatheter Aortic Valve Replacement (`cardio:pubmed-27815101`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: 7d142c1b63a51d581a415fab5098456ab7703518ae1797786bdb301c732d111d
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
